SDIASX:SDI 61 EBITDA Margin % is 14.74% as of Dec. 2025, which is 15% below its 10-year median of 17.36. GuruFocus rates ASX:SDI with a GF Score™ of 61/100 and a GF Value™ of A$0.96 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 816 Medical Devices & Instruments companies, SDI ranks better than 72.79% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. SDI's EBITDA for the
six
months ended in Dec. 2025 was A$7.8 Mil. SDI's Revenue for the
six
months ended in Dec. 2025 was A$52.9 Mil. Therefore, SDI's EBITDA margin for the quarter that ended in Dec. 2025 was 14.74%.
SDI (ASX:SDI) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
SDI EBITDA Margin % Related Terms
SDI EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for SDI's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:SDI vs ISRG, BDX, MDLN: EBITDA Margin % Comparison
For the Medical Instruments & Supplies subindustry, SDI's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SDI EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, SDI's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where SDI's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SDI (ASX:SDI) has a EBITDA Margin % of 14.74% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on SDI and its competitors. This is 15% below median its historical median of 17.36. Over the past decade, SDI's EBITDA Margin % has ranged from 14.16 to 21.20. According to the industry distribution chart, SDI ranks #222 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 27.2%.
Is SDI's EBITDA Margin % too high?
SDI's current EBITDA Margin % of 14.74% is 15% below median its 10-year median of 17.36. Over the past 10 years, this metric has ranged from a low of 14.16 to a high of 21.20. The Medical Devices & Instruments industry median EBITDA Margin % is 7.48. SDI's value of 14.74% is 97.2% above this industry median. Based on the distribution chart, SDI ranks #222 out of 816 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, SDI has a GF Score™ of 61/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does SDI's EBITDA Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, SDI ranks #222 out of 816 companies for EBITDA Margin %. This puts SDI in the upper half of its industry. The industry median EBITDA Margin % is 7.48. SDI's value of 14.74% is 97.2% above this benchmark. Historically, SDI's own EBITDA Margin % has ranged from 14.16 to 21.20 over the past decade. While the company's 10-year median is 17.36 vs. the industry median of 7.48, SDI has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.48, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SDI's current EBITDA Margin % of 14.74% is 97.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on SDI and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SDI's current EBITDA Margin % is 14.74%, which is 15% below median its own 10-year median of 17.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SDI stock overvalued right now?
Based on GuruFocus' analysis, SDI (ASX:SDI) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.96, compared to a current price of A$1.40 — trading 45.6% above its estimated fair value. The current EBITDA Margin % is 14.74%, which is 15% below median its 10-year median of 17.36 and 97.2% above the Medical Devices & Instruments industry median of 7.48. SDI's overall GF Score™ is 61/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For SDI (ASX:SDI), the current EBITDA Margin % is 14.74% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SDI (ASX:SDI) Overvalued in 2026?
Based on GuruFocus' analysis, SDI stock appears to be overvalued.
The current stock price of A$1.40 is trading 45.6% above its estimated GF Value™ of A$0.96.
GuruFocus considers SDI to be Significantly Overvalued.
Key valuation signals for ASX:SDI:
EBITDA Margin %: 14.74% (15% below median its 10-year median of 17.36)
GF Value™: A$0.96 vs. price of A$1.40 (45.6% above fair value)
Industry Position: 97.2% above the Medical Devices & Instruments median (#222 of 816)
No single metric tells the full story. See the ASX:SDI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SDI Ltd is engaged in the research and development, manufacturing, and marketing of specialist dental materials. Its products include dental accessories, adhesives, cements, composites, equipment, sealants, tooth whitening, and others. The company's geographical segments includes Australia; Europe; USA and Brazil. It derives a majority of revenue from Australia.
61GF Score
Get the complete analysis for ASX:SDI
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:SDI has been successfully added to your 
